The New York Times - Business:
An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.
This post first appeared in The New York Times - Business. Read the original article.
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
